Sputnik V: interested countries condition the decision pending certification of its scientific “suitability”

The Russian vaccine still adds international skepticism to announcements considered premature.  Even several negotiations are subject to waiting for more details.  NA
The Russian vaccine still adds international skepticism to announcements considered premature. Even several negotiations are subject to waiting for more details. NA

Named “Sputnik V” in homage to the first satellite launched by the USSR in 1957, the Russian vaccine adds international skepticism to announcements considered premature. Even several negotiations are subject to waiting for more details.

In total, more than 50 countries – including India, Brazil, China, Argentina, Belarus, Hungary, Venezuela, Nepal, Uzbekistan, Egypt, Mexico and Kazakhstan – have demanded this candidate, orders that would amount to more than 1.2 billion doses. However, with the exception of the application that has already begun to be deployed in the Argentina and Belarus, the rest of the countries that have expressed interest they condition their orders to a certification of “suitability” confirming its effectiveness.

Hungary, which joined the few states to receive doses, has 6,000 ampoules available since yesterday. Despite the stock – and like other countries that have shown concern about this development – its application program will remain conditional on the decision of a group of Hungarian experts. The confirmation was given by Foreign Minister Peter Szijjarto, who did not provide further information on the possible deployment of Russian development, which now depends on the review of the Budapest health officials.

“Under our previous agreement, the cooperation of Russia and Hungary regarding the coronavirus vaccine will continue (…) 6,000 doses of the Russian vaccine have reached Hungary,” the Hungarian head of diplomacy wrote on his account. From Facebook.

Hungarian doctors and experts visited Russian production sites for the vaccine. According to the Budapest government, mass production of Sputnik V in Hungary could begin next year “if the vaccine proves safe and effective.”

With the arrival of the drug from Moscow, the government of the nationalist prime minister, Viktor Orban, differs from the rest of its partners in the European Union with regard to this vaccine. For Brussels, the lack of scientific information is an obstacle to issuing favorable criteria. Hungary furthermore puts itself outside the European requirement for centralized regulation of the Union Medical Agency (EMA).

In Algeria, another country that seeks to apply this vaccine, there are also divergences, although the authorities of the National Order of Physicians and the scientific committee covid-19 have tried to dispel doubts. Without questioning its effectiveness, the conditions of use are in a state of approval “a priori”. The country, which hopes to produce it locally, postpones definitions for the month of January.

Brazil was another country to make public its desire to apply it. However, for now the agreement is provisional and would only leave the use to interested states. In that sense, Bahia, in the northeast, communicated this idea through its Ministry of Health, for an eventual supply of up to 50 million doses. Other states have been inclined towards the development of the Chinese laboratory Sinovac, which they consider the most advanced candidate and with the capacity to guarantee millions of doses in the coming months, some 45 million doses.

Argentina and Belarus differ

Belarus announced on Tuesday the launch of its vaccination campaign against the new coronavirus with the arrival in the country of the first batch of Russian Sputnik V vaccines.

The Ministry of Health of the former Soviet Republic, was responsible for the announcement: “The first batch of vaccine arrived in Belarus and the vaccination of the population begins.”

Belarus was the first foreign country to license the Russian vaccine on its territory in December. Clinical trials have been conducted there since October 1.

With the announcement, together with Argentina they have become the first countries, after Russia, to begin vaccinating their population with Sputnik V.

Argentina and Belarus have become the first countries, after Russia, to begin vaccinating their population with Sputnik V. (Presidency)
Argentina and Belarus have become the first countries, after Russia, to begin vaccinating their population with Sputnik V. (Presidency)

Russia began to inoculate in early December with workers at risk and occupations considered “priority”, without good in people between 18 and 60 years. Vaccination for the elderly begins in the next few days.

Orders without specifications.

The government of President Vladimir Putin has begun delivering its Sputnik V vaccine to the African continent. This was confirmed by the Vice Minister of Foreign Affairs, Mikhail Bogdanov, who did not specify which countries are affected.

The Deputy Foreign Minister, Mikhail Bogdanov, confirmed the demand on the African continent, although he did not specify which countries are affected.  EFE
The Deputy Foreign Minister, Mikhail Bogdanov, confirmed the demand on the African continent, although he did not specify which countries are affected. EFE

“Deliveries of the Russian vaccine against the Sputnik V coronavirus to Africa have already begun,” he told a Russian media, without indicating the requesting countries.

According to the Russian diplomat, the interest is “enormous” and there are currently “many requests”.

“We don’t want to offend anyone. We would like all the calls that we have received from our African friends to be satisfied, ”the deputy minister stressed.

Phase 3, just in May.

On August 11, Russia registered the first vaccine against covid-19, called Sputnik V and developed by the Nikolai Gamaleya Center for Epidemiology and Microbiology.

The vaccine consists of two components: the first is based on human adenovirus type 26, and the second is based on recombinant human adenovirus type 5. The drug is administered twice, at an interval of 21 days.

The third phase of its clinical trials should conclude in May, at which time publication in scientific media is expected. According to the advance of the results, the analyzes performed 21 days after the administration of the first component, the drug met the endpoints of the third phase by showing an effectiveness of 91.4%.

Finally, for the countries that have advanced orders, the production and delivery capacity is another determining factor. Vladimir Putin himself exposed at the time the difficulties for its manufacture, a doubt that was later cleared by the Kremlin itself, who now guarantees its distribution, especially for the two countries that today began to inject it.

MORE ON THIS TOPIC:

These are the 50 people who got richer during the pandemic: more than half are Chinese

Russia declared three journalists, an artist and a human rights defender critical of Vladimir Putin as “foreign agents”

Leave a Comment